Clinical trial

Full-scale Intervention Study: Genetic Risk Communication and Wearables

NCT05524909

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-11-01

PhaseNA

Study timeline

Study start (actual)2022-11-01Date precision: day

Registry last updated2026-05-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Fitness Trackersunresolved

Physical Activityunresolved

Exerciseunresolved

Genetic Predisposition to Diseaseunresolved

Type 2 Diabetesverified · MONDO: type 2 diabetes mellitus

Interventions

Genetic Risk EstimateGENETIC

Genetic Risk Estimate + Fitbit FunctionsDEVICE

Sponsors & collaborators

The University of Hong Konglead sponsor

Mapped research locations

Hong KongHong Kong1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05524909 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.